CT26-hTROP2
Strain Information
Validation Data
Fig.1 hTROP2 expression on in vitro cultured cells of CT26-hTROP2.
Fig.2 In vivo validation of CT26-hTROP2 in BALB/c mice.BALB/c mice were inoculated with CT26-hTROP2 subcutaneously at 3×106 cells/mouse inoculum for tumor development. The day of vaccination for mice is defined as Day 0, and tumor measurement and weight measurement begin on the 7th day after vaccination, twice a week.
Fig.3 hTROP2 expression in tumors after in vivo growth of CT26-hTROP2 in wild type BALB/c mice.When the MTV reaches 500-800 mm3, take one tube from each group and send it to FACS for testing (Markers: L/D, mCD45, hTROP2). A，the MTV reaches 800 mm3. B，the MTV reaches 1500 mm3.
Related Strain(s)
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreOur vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.
Learn more
